Merck to open new distribution centre in Brazil for Life Science sector
The facility, which will be operational this month, is designed to meet the increasing demand for life science products in the region. Spanning 13,000m2, the centre is twice
The US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has voted in favour of Bristol Myers Squibb (BMS) and 2seventy bio’s Abecma (idecabtagene vicleucel) for treating triple-class exposed relapsed or refractory multiple myeloma.